Insiders · Profile

Innovative Cellular Therapeutics Holdings Ltd

10% owner at Lyell Immunopharma. Filing since 16 Jul 2026. CIK 0002095697

Company
Date
Role
Action
Shares
Amount
Of holding
17 Jul 2026
10% owner
Sold on a plan
10
$137.00
0.0%
16 Jul 2026
10% owner
Sold on a plan
10
$137.30
0.0%
2 decisions on file.